Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial

OBJECTIVE: Mucoactive drugs should increase the ability to expectorate sputum and, ideally, have anti-inflammatory properties. The aim of the study was to evaluate the mucolytic activity of Tyloxapol compared to saline (0.9%) in COPD. DESIGN: A randomized, placebo-controlled, double-blinded crossove...

Descripción completa

Detalles Bibliográficos
Autores principales: Koppitz, Martin, Eschenburg, Charlotte, Salzmann, Emilia, Rosewich, Martin, Schubert, Ralf, Zielen, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911120/
https://www.ncbi.nlm.nih.gov/pubmed/27308826
http://dx.doi.org/10.1371/journal.pone.0156999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911120/
https://www.ncbi.nlm.nih.gov/pubmed/27308826
http://dx.doi.org/10.1371/journal.pone.0156999

Ejemplares similares